OUR STORY
Worldwide Collaboration Advancing Hope
CBTN drives bold discovery, pioneers new treatments, and accelerates open science to improve the health of all children diagnosed with brain tumors.
CBTN drives bold discovery, pioneers new treatments, and accelerates open science to improve the health of all children diagnosed with brain tumors.
CBTN is set up as a research study that follows patients from diagnosis and tracks their progression throughout the treatment journey.
Operations are led from the Center for Data Driven Discovery in Biomedicine (D3b) at Children’s Hospital of Philadelphia (CHOP), with an executive oversight team drawn from top pediatric research institutions across the world.